Listar por autor "Savarese, Gianluigi"
Mostrando ítems 1-6 de 6
-
A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry
Kaplon-Cieslicka, Agnieszka; Benson, Lina; Chioncel, Ovidiu; Crespo-Leiro, María Generosa; Coats, Andrew J.S.; Anker, Stefan; Filippatos, Gerasimos; Ruschitzka, Frank; Hage, Camilla; Drozdz, Jaroslaw; Seferovic, Petar; Rosano, Giuseppe M.C.; Piepoli, Massimo; Mebazaa, Alexandre; McDonagh, Theresa; Lainscak, Mitja; Savarese, Gianluigi; Ferrari, Roberto; Maggioni, Aldo P.; Lund, Lars H. (Wiley, 2021-12-27)[Abstract] Aims: To perform a comprehensive characterization of acute heart failure (AHF) with preserved (HFpEF), versus mildly reduced (HFmrEF) versus reduced ejection fraction (HFrEF). Methods and results: Of 5951 ... -
Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes – from the ESC-HFA EORP Heart Failure Long-Term Registry
Kaplon-Cieslicka, Agnieszka; Benson, Lina; Chioncel, Ovidiu; Crespo-Leiro, María Generosa; Coats, Andrew J.S.; Anker, Stefan; Ruschitzka, Frank; Hage, Camilla; Drozdz, Jaroslaw; Seferovic, Petar; Rosano, Giuseppe; Piepoli, Massimo; Mebazaa, Alexandre; McDonagh, Theresa; Lainscak, Mitja; Savarese, Gianluigi; Ferrari, Roberto; Mullens, Wilfried; Bayes-Genis, Antoni; Maggioni, Aldo P.; Lund, Lars H. (European Society of Cardiology, 2023-04-27)[Abstract] Aims: To comprehensively assess hyponatraemia in acute heart failure (AHF) regarding prevalence, associations, hospital course, and post-discharge outcomes. Methods and results: Of 8298 patients in the European ... -
Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry
Kapelios, Chris J.; Benson, Lina; Crespo-Leiro, María Generosa; Anker, Stefan; Coats, Andrew J.S.; Chioncel, Ovidiu; Filippatos, Gerasimos; Lainscak, Mitja; McDonagh, Theresa; Mebazaa, Alexandre; Metra, Marco; Piepoli, Massimo F.; Rosano, Giuseppe M.C.; Ruschitzka, Frank; Savarese, Gianluigi; Seferovic, Petar M.; Volterrani, Maurizio; Maggioni, Aldo P.; Lund, Lars H. (2023-03-04) -
Prevalence, characteristics and prognostic impact of aortic valve disease in patients with heart failure and reduced, mildly reduced, and preserved ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry
Shahim, Bahira; Shahim, Angiza; Adamo, Marianna; Chioncel, Ovidiu; Benson, Lina; Crespo-Leiro, María Generosa; Anker, Stefan D.; Coats, Andrew J.S.; Filippatos, Gerasimos; Lainscak, Mitja; McDonagh, Theresa; Mebazaa, Alexandre; Piepoli, Massimo F.; Rosano, Giuseppe M.C.; Ruschitzka, Frank; Savarese, Gianluigi; Seferovic, Petar; Volterrani, Maurizio; Segovia-Cubero, Javier; Amir, Offer; Palic, Benjamin; magg, Aldo P.; Metra, Marco; Lund, Lars H. (Wiley, 2023-05-21)[Abstract] Aims: To assess the prevalence, clinical characteristics, and outcomes of patients with heart failure (HF) with or without moderate to severe aortic valve disease (AVD) (aortic stenosis [AS], aortic regurgitation ... -
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world
Kapelios, Chris J.; Lainscak, Mitja; Savarese, Gianluigi; Laroche, Cécile; Seferovic, Petar; Ruschitzka, Frank; Coats, Andrew; Anker, Stefan; Crespo-Leiro, María Generosa; Filippatos, Gerasimos; Piepoli, Massimo; Rosano, Giuseppe; Zanolla, Luisa; Aguiar, Carlos; Murin, Jan; Leszek, Przemyslaw; McDonagh, Theresa; Maggioni, Aldo P.; Lund, Lars H. (Wiley, 2019-05-27)[Abstract] Aims: To assess the proportion of patients with heart failure and reduced ejection fraction (HFrEF) who are eligible for sacubitril/valsartan (LCZ696) based on the European Medicines Agency/Food and Drug ... -
Unravelling the Interplay Between Hyperkalaemia, Renin–Angiotensin–Aldosterone Inhibitor Use and Clinical Outcomes. Data From 9222 Chronic Heart Failure Patients of the ESC‐HFA‐EORP Heart Failure Long‐Term Registry
Rossignol, Patrick; Lainscak, Mitja; Crespo-Leiro, María Generosa; Laroche, Cécile; Piepoli, Massimo Francesco; Filippatos, Gerasimos; Rosano, Giuseppe; Savarese, Gianluigi; Anker, Stefan; Seferovic, Petar M.; Ruschitzka, Frank; Coats, Andrew J.S.; Mebazaa, Alexandre; McDonagh, Theresa; Sahuquillo-Martínez, Ana; Penco, María; Maggioni, Aldo P.; Lund, Lars H. (Willey Online Library, 2020-04-03)[Abstract] Aims. We assessed the interplay between hyperkalaemia (HK) and renin–angiotensin–aldosterone system inhibitor (RAASi) use, dose and discontinuation, and their association with all‐cause or cardiovascular death ...